Hyeon-Seon Ji

Title: Hyeon-Seon Ji: Innovator in Metabolic Syndrome Treatment

Introduction

Hyeon-Seon Ji is a prominent inventor based in Yuseong-gu, Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the prevention and treatment of metabolic syndrome. His innovative work focuses on utilizing natural extracts to enhance health outcomes.

Latest Patents

Hyeon-Seon Ji holds a patent for a composition aimed at the prevention or treatment of metabolic syndrome or for antioxidation. This composition includes black soybean leaf extracts and flavonol glycoside compounds as active ingredients. The patent highlights the effectiveness of these extracts in inhibiting α-glucosidase activity, LDL oxidation, and DDP-4. Additionally, it demonstrates excellent DPPH radical scavenging activity and the ability to promote insulin secretion. The composition also regulates the expression of major genes and improves various health markers, such as reducing waist/hip circumference and decreasing plasma free fatty acids.

Career Highlights

Hyeon-Seon Ji is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work has garnered attention for its potential impact on public health, particularly in addressing metabolic disorders. His research emphasizes the importance of natural compounds in developing effective treatments.

Collaborations

Hyeon-Seon Ji collaborates with notable colleagues, including Tae Sook Jeong and Ho Yong Park. Their combined expertise contributes to advancing research in the field of biotechnology and health.

Conclusion

Hyeon-Seon Ji's innovative contributions to the treatment of metabolic syndrome through natural extracts highlight the potential of biotechnology in improving health outcomes. His work continues to inspire further research and development in this vital area.